Repository logo
 
Publication

Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cells

dc.contributor.authorGonçalves Teixeira, Ricardo
dc.contributor.authorBrás, Ana Rita
dc.contributor.authorCôrte-Real, Leonor
dc.contributor.authorTatikonda, Rajendhraprasad
dc.contributor.authorSanches, Anabela
dc.contributor.authorRobalo, Maria Paula
dc.contributor.authorAvecilla, Fernando
dc.contributor.authorMoreira, Tiago
dc.contributor.authorGarcia, M. Helena
dc.contributor.authorHaukka, Matti
dc.contributor.authorPreto, Ana
dc.contributor.authorValente, Andreia
dc.date.accessioned2017-12-07T12:05:12Z
dc.date.available2017-12-07T12:05:12Z
dc.date.issued2017-12-02
dc.description.abstractThree new compounds have been synthesized and completely characterized by analytical and spectroscopic techniques. The new bipyridine-perfluorinated ligand L1 and the new organometallic complex [Ru(η5-MeCp)(PPh3)2Cl] (Ru1) crystalize in the centrosymmetric triclinic space group P <img height="13" border="0" style="vertical-align:bottom" width="11" alt="View the MathML source" title="View the MathML source" src="http://origin-ars.els-cdn.com/content/image/1-s2.0-S0223523417309625-si1.gif">1¯. Analysis of the phenotypic effects induced by both organometallic complexes Ru1 and [Ru(η5-MeCp)(PPh3)(L1)][CF3SO3] (Ru2), on human colorectal cancer cells (SW480 and RKO) survival, showed that Ru2 has a potent anti-proliferative activity, 4–6 times higher than cisplatin, and induce apoptosis in these cells. Data obtained in a noncancerous cell line derived from normal colon epithelial cells (NCM460) revealed an intrinsic selectivity of Ru2 for malignant cells at low concentrations, showing the high potential of this compound as a selective anticancer agent.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationTEIXEIRA, Ricardo G.; [et al] – Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cells. European Journal of Medicinal Chemistry. ISSN: 0223-5234. Vol. 143, (2017), pp. 503-514.pt_PT
dc.identifier.doihttps://doi.org/10.1016/j.ejmech.2017.11.059pt_PT
dc.identifier.issn0223-5234
dc.identifier.urihttp://hdl.handle.net/10400.21/7669
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevierpt_PT
dc.relation.publisherversionhttps://ac.els-cdn.com/S0223523417309625/1-s2.0-S0223523417309625-main.pdf?_tid=bb903972-db43-11e7-9c33-00000aacb362&acdnat=1512647141_93ba39e1dea8803610923a1e6708b22dpt_PT
dc.subjectRuthenium methylcyclopentadienylpt_PT
dc.subjectColorectal cancerpt_PT
dc.subjectApoptosispt_PT
dc.subjectSelectivitypt_PT
dc.titleNovel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cellspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/5876/UID%2FQUI%2F00100%2F2013/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/5876/UID%2FBIA%2F04050%2F2013/PT
oaire.citation.endPage514pt_PT
oaire.citation.startPage503pt_PT
oaire.citation.titleEuropean Journal of Medicinal Chemistrypt_PT
oaire.fundingStream5876
oaire.fundingStream5876
person.familyNameGonçalves Teixeira
person.familyNameCôrte-Real
person.familyNameTatikonda
person.familyNameRobalo
person.familyNameAvecilla
person.familyNameMoreira
person.familyNamePreto
person.familyNameValente
person.givenNameRicardo
person.givenNameLeonor
person.givenNameRajendhraprasad
person.givenNameMaria Paula
person.givenNameFernando
person.givenNameTiago
person.givenNameAna
person.givenNameAndreia
person.identifierH-8112-2012
person.identifier1550953
person.identifier.ciencia-id8119-2DA0-7EC3
person.identifier.ciencia-idF112-59D7-0984
person.identifier.ciencia-idE11C-A704-9C18
person.identifier.ciencia-id3118-8F87-B8B7
person.identifier.ciencia-idC81F-9F8C-1790
person.identifier.ciencia-id9F1B-8F8A-EBE6
person.identifier.orcid0000-0002-1028-0486
person.identifier.orcid0000-0002-4974-1075
person.identifier.orcid0000-0003-1277-3492
person.identifier.orcid0000-0002-8200-6910
person.identifier.orcid0000-0002-4547-1020
person.identifier.orcid0000-0003-3817-7103
person.identifier.orcid0000-0002-7302-0630
person.identifier.orcid0000-0002-3370-208X
person.identifier.ridL-7014-2017
person.identifier.ridH-5636-2013
person.identifier.ridB-2002-2012
person.identifier.ridD-9251-2011
person.identifier.scopus-author-id55627880500
person.identifier.scopus-author-id9269662100
person.identifier.scopus-author-id57216396317
person.identifier.scopus-author-id6602508305
person.identifier.scopus-author-id23570219600
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsclosedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication8dfbd114-7328-47a9-a6d5-877463271483
relation.isAuthorOfPublicationf28f9ab9-bbe1-4a86-8a25-3a24538cecec
relation.isAuthorOfPublicationf0a2d5cd-4236-452e-8b68-60fc728e939f
relation.isAuthorOfPublication823a9498-17ab-451f-bb8f-56338643ac0c
relation.isAuthorOfPublication2a229b3b-e00f-459c-8fd6-d5773d536d3b
relation.isAuthorOfPublication84e29b9e-e3be-40ba-b9a3-29273bdf47df
relation.isAuthorOfPublication5b7e553f-83da-46eb-a273-720ab27a95a1
relation.isAuthorOfPublicationbde545e4-9e4b-4287-8bc5-ee9e2942ed8f
relation.isAuthorOfPublication.latestForDiscovery84e29b9e-e3be-40ba-b9a3-29273bdf47df
relation.isProjectOfPublication42e2c67b-cc38-4020-bc4d-950bf9ae00c9
relation.isProjectOfPublication033d966d-4535-4242-b0f6-ad5730d78fe1
relation.isProjectOfPublication.latestForDiscovery42e2c67b-cc38-4020-bc4d-950bf9ae00c9

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Novel_MPRobalo_ADEQ.pdf
Size:
3.51 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: